产品简要
公司名称 :
伯乐（Bio-Rad）公司
其他品牌 :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
产品类型 :
抗体
产品名称 :
MOUSE抗主要研究者-3 KINASE p85亚单位甲
目录 :
MCA1167G
规格 :
0.2毫克
价格 :
394美元
克隆性 :
单克隆
宿主 :
小鼠
共轭标签 :
未共轭
克隆名称 :
U5
反应物种 :
人类, 小鼠, 大鼠, 牛
应用 :
免疫印迹, 免疫沉淀
更多信息或购买 :
图像
图像 1 :
Jurkat Whole Cell lysate probed with Mouse anti PI-3 Kinase p85 Alpha subunit (MCA1167G)
产品信息
Entity Type :
单克隆抗体
Entity Category :
抗体
ProductCode :
MCA1167G
描述 :
MOUSE抗主要研究者-3 KINASE p85亚单位甲
特异性 :
主要研究者-3 KINASE p85亚单位甲
目标物种 :
牛
宿主 :
小鼠
格式 :
纯化
Isotypes :
IgG1
应用 :
C, 免疫沉淀, 免疫印迹
ApplicationTypes :
Western Blotting,Immunoprecipitation,Immunohistology - Frozen
交叉活性 :
Mouse,Rat,Human,Monkey
克隆 :
U5
规格 :
0.2毫克
Quantity Value :
0.2
规格类型 :
毫克
GO登录号 :
GO:0033574, GO:0043200, GO:0043548, GO:0043551, GO:0043560, GO:0045471, GO:0045663, GO:0045768, GO:0045776, GO:0045861, GO:0048009, GO:0048662, GO:0051117, GO:0051219, GO:0051591, GO:0070848, GO:0071398, GO:0071445, GO:0071548, GO:0090004, GO:0060396, GO:0050900, GO:0050852, GO:0048011, GO:0048009, GO:0046854, GO:0044419, GO:0016303, GO:0030183, GO:0030335, GO:0035014, GO:0043066, GO:0043560, GO:0045671, GO:0048009, GO:0005159, GO:0005943, GO:0006468, GO:0008286, GO:0043125, GO:0005158, GO:0001953, GO:0005886, GO:0001878, GO:0001934, GO:0043125, GO:0005158, GO:0005159, GO:0005161, GO:0005516, GO:0005625, GO:0005634, GO:0005943, GO:0006006, GO:0030971, GO:0007584, GO:0008022, GO:0008286, GO:0042493, GO:0009750, GO:0010040, GO:0010459, GO:0010628, GO:0016303, GO:0046935, GO:0019717, GO:0019901, GO:0019904, GO:0022408, GO:0030331, GO:0030335, GO:0031625, GO:0032355, GO:0032570, GO:0043125, GO:0090004, GO:0048009, GO:0046854, GO:0043560, GO:0035014, GO:0046326, GO:0008286, GO:0043125, GO:0005158, GO:0005943, GO:0005159, GO:0043560, GO:0043559, GO:0035014, GO:0031295, GO:0030168, GO:0048015, GO:0019903, GO:0046326, GO:0014065, GO:0008543, GO:0008286, GO:0007173, GO:0005943, GO:0005545, GO:0005159, GO:0005158
GOTerms :
HER3 receptor binding,Neu/ErbB-2 receptor activity,insulin receptor ligand,GO:0005067,IGF receptor binding,insulin-like growth factor,insulin-like growth factor receptor ligand,1-phosphatidylinositol-4-phosphate kinase, class IA complex,class IA PI3K complex,GO:0035030,phosphoinositide 3-kinase complex, class IA,daf-2 receptor signaling pathway,insulin receptor signalling pathway,activation of glucose import,positive regulation of glucose uptake,stimulation of glucose import,up regulation of glucose import,upregulation of glucose import,up-regulation of glucose import,phosphoinositide 3-kinase regulator activity,PI3K regulator activity,insulin receptor substrate [protein] binding,IRS [protein] binding,IRS binding,GO:0046837,phosphatidylinositol phosphate biosynthetic process,phosphatidylinositol phosphate phosphorylation,phosphoinositide phosphorylation,PIP biosynthesis,PtdInsP biosynthesis,IGF receptor signaling pathway,IGF receptor signalling pathway,positive regulation of establishment of protein localisation in plasma membrane,HER3 receptor binding,Neu/ErbB-2 receptor activity,insulin receptor ligand,GO:0005067,IGF receptor binding,insulin-like growth factor,insulin-like growth factor receptor ligand,1-phosphatidylinositol-4-phosphate kinase, class IA complex,class IA PI3K complex,GO:0035030,phosphoinositide 3-kinase complex, class IA,EGF receptor signaling pathway,EGF receptor signalling pathway,EGFR signaling pathway,epidermal growth factor receptor signalling pathway,daf-2 receptor signaling pathway,insulin receptor signalling pathway,FGF receptor signaling pathway,FGF receptor signalling pathway,FGFR signaling pathway,fibroblast growth factor receptor signalling pathway,phosphoinositide 3-kinase cascade,PI 3-kinase cascade,PI3K cascade,activation of glucose import,positive regulation of glucose uptake,stimulation of glucose import,up regulation of glucose import,upregulation of glucose import,up-regulation of glucose import,inositol phospholipid-mediated signaling,phosphatidylinositol-mediated signalling,phosphoinositide-mediated signaling,phosphoinositide-mediated signalling,blood coagulation, platelet activation,T cell co-stimulation,T lymphocyte costimulation,T-cell costimulation,T-cell co-stimulation,T-lymphocyte costimulation,phosphoinositide 3-kinase regulator activity,PI3K regulator activity,insulin receptor substrate [protein] binding,IRS [protein] binding,IRS binding,interaction with another species,interspecies interaction,interspecies interaction with other organisms,GO:0046837,phosphatidylinositol phosphate biosynthetic process,phosphatidylinositol phosphate phosphorylation,phosphoinositide phosphorylation,PIP biosynthesis,PtdInsP biosynthesis,IGF receptor signaling pathway,IGF receptor signalling pathway,nerve growth factor receptor signalling pathway,NGF receptor signaling pathway,NGF receptor signalling pathway,T lymphocyte receptor signaling pathway,T lymphocyte receptor signalling pathway,T-cell receptor signaling pathway,T-cell receptor signalling pathway,TCR signaling pathway,T-lymphocyte receptor signaling pathway,T-lymphocyte receptor signalling pathway,immune cell migration,immune cell trafficking,leucocyte migration,leucocyte trafficking,leukocyte trafficking,cellular response to growth hormone,GH receptor signaling pathway,growth hormone receptor signalling pathway,positive regulation of establishment of protein localisation in plasma membrane,down regulation of cell-matrix adhesion,down-regulation of cell-matrix adhesion,downregulation of cell-matrix adhesion,inhibition of cell-matrix adhesion,HER3 receptor binding,Neu/ErbB-2 receptor activity,insulin receptor ligand,GO:0005067,IGF receptor binding,insulin-like growth factor,insulin-like growth factor receptor ligand,1-phosphatidylinositol-4-phosphate kinase, class IA complex,class IA PI3K complex,GO:0035030,phosphoinositide 3-kinase complex, class IA,protein amino acid phosphorylation,daf-2 receptor signaling pathway,insulin receptor signalling pathway,1-phosphatidylinositol 3-kinase activity,ATP:1-phosphatidyl-1D-myo-inositol 3-phosphotransferase activity,GO:0004429,phosphatidylinositol 3-kinase activity, class I,phosphatidylinositol 3-kinase activity, class II,phosphatidylinositol 3-kinase activity, class III,phosphatidylinositol 3-kinase, class I, catalyst activity,PI3K,PI3-kinase activity,PtdIns-3-kinase activity,type I phosphatidylinositol kinase activity,type III phosphoinositide 3-kinase activity,Vps34p,B cell development,B lymphocyte differentiation,B-cell differentiation,B-lymphocyte differentiation,GO:0042115,activation of cell migration,stimulation of cell migration,up regulation of cell migration,upregulation of cell migration,up-regulation of cell migration,phosphoinositide 3-kinase regulator activity,PI3K regulator activity,down regulation of apoptosis,downregulation of apoptosis,down-regulation of apoptosis,inhibition of apoptosis,insulin receptor substrate [protein] binding,IRS [protein] binding,IRS binding,down regulation of osteoclast differentiation,downregulation of osteoclast differentiation,down-regulation of osteoclast differentiation,inhibition of osteoclast differentiation,IGF receptor signaling pathway,IGF receptor signalling pathway,bacterial inner membrane,cell membrane,cytoplasmic membrane,GO:0005904,inner endospore membrane,juxtamembrane,plasma membrane lipid bilayer,plasmalemma,activation of protein amino acid phosphorylation,positive regulation of protein amino acid phosphorylation,stimulation of protein amino acid phosphorylation,up regulation of protein amino acid phosphorylation,upregulation of protein amino acid phosphorylation,up-regulation of protein amino acid phosphorylation,HER3 receptor binding,Neu/ErbB-2 receptor activity,insulin receptor ligand,GO:0005067,IGF receptor binding,insulin-like growth factor,insulin-like growth factor receptor ligand,PDGF,PDGF receptor binding,PDGFR binding,platelet-derived growth factor,platelet-derived growth factor receptor ligand,soluble,cell nucleus,1-phosphatidylinositol-4-phosphate kinase, class IA complex,class IA PI3K complex,GO:0035030,phosphoinositide 3-kinase complex, class IA,cellular glucose metabolic process,glucose metabolism,transmembrane receptor protein tyrosine kinase ligand binding,nutritional response pathway,response to nutrients,carboxylate-terminal binding,carboxylate-terminus binding,carboxyl-terminal binding,carboxyl-terminus binding,carboxy-terminal binding,carboxy-terminus binding,COOH-terminal binding,COOH-terminus binding,C-terminal binding,C-terminal end binding,daf-2 receptor signaling pathway,insulin receptor signalling pathway,drug resistance,drug susceptibility/resistance,GO:0017035,response to iron(II),1-phosphatidylinositol 3-kinase activity,ATP:1-phosphatidyl-1D-myo-inositol 3-phosphotransferase activity,GO:0004429,phosphatidylinositol 3-kinase activity, class I,phosphatidylinositol 3-kinase activity, class II,phosphatidylinositol 3-kinase activity, class III,phosphatidylinositol 3-kinase, class I, catalyst activity,PI3K,PI3-kinase activity,PtdIns-3-kinase activity,type I phosphatidylinositol kinase activity,type III phosphoinositide 3-kinase activity,Vps34p,1-phosphatidylinositol 3-kinase regulator activity,phosphatidylinositol 3-kinase, class I, regulator activity,protein domain-specific binding,down regulation of cell-cell adhesion,down-regulation of cell-cell adhesion,downregulation of cell-cell adhesion,inhibition of cell-cell adhesion,activation of cell migration,stimulation of cell migration,up regulation of cell migration,upregulation of cell migration,up-regulation of cell migration,ubiquitin ligase binding,response to E2 stimulus,GO:0010237,response to amino acid,phosphoinositide 3-kinase binding,PI3K binding,regulation of phosphoinositide 3-kinase activity,insulin receptor substrate [protein] binding,IRS [protein] binding,IRS binding,GO:0017036,activation of myoblast differentiation,stimulation of myoblast differentiation,up regulation of myoblast differentiation,upregulation of myoblast differentiation,up-regulation of myoblast differentiation,activation of anti-apoptosis,stimulation of anti-apoptosis,up regulation of anti-apoptosis,up-regulation of anti-apoptosis,upregulation of anti-apoptosis,down regulation of blood pressure,downregulation of blood pressure,down-regulation of blood pressure,inhibition of blood pressure,down regulation of proteolysis,downregulation of proteolysis,down-regulation of proteolysis,inhibition of proteolysis,negative regulation of peptidolysis,IGF receptor signaling pathway,IGF receptor signalling pathway,down regulation of smooth muscle cell proliferation,downregulation of smooth muscle cell proliferation,down-regulation of smooth muscle cell proliferation,inhibition of smooth muscle cell proliferation,negative regulation of SMC proliferation,phosphorylated protein binding,response to 3',5' cAMP,response to 3',5'-cAMP,response to adenosine 3',5'-cyclophosphate,response to cyclic AMP
UniProt数据库登录号 :
P26450, P27986, P23727, Q63787
基因 :
磷酸肌醇3激酶调节亚单位1, 磷酸肌醇3激酶调节亚单位1, 磷酸肌醇3激酶调节亚单位1, 磷酸肌醇3激酶调节亚单位1
GeneID网址 :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=282307, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=5295, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=18708, http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=25513
Entity Formats :
纯化, S/N
UNSPSC :
41116161
浓度 :
IgG浓度1.0毫克/毫升
产品形式 :
纯化IgG-液体
PriceGBP :
281
PriceEUR :
394
PriceUSD :
394美元
PriceCHF :
429
PriceSEK :
4295
PriceNOK :
4316
PriceDKK :
2938
更多信息或购买 :
公司信息
伯乐（Bio-Rad）公司
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com44-1865-852-700
公司总部: 英国
伯乐（Bio-Rad）公司是世界领先的抗体生产商之一。通过其原名为AbD Serotec公司的专业抗体业务团队，提供超过12,000种抗体及相关试剂，专注于免疫学、肿瘤、兽医研究及细胞生物学等领域。
抗体产品包括细胞凋亡试剂盒，自噬检测试剂，CD分子标记物，标签抗体，免疫学研究抗体，神经科学研究抗体和兽医应用试剂等。
伯乐（Bio-Rad）公司在英国拥有经ISO9001和ISO13485认证的生产厂房，同时在德国和美国均设有经ISO9001认证的厂房。
我们专业领域已扩展到传统和重组抗体制备及生产服务。我们的抗体定制服务仅需8周就能完成抗体制备并且成功率在90%以上。我们的体外重组抗体技术能够使得我们筛选制备针对具有挑战性的靶点的抗体，确保长期稳定供货，并能够提供抗体的相应基因序列。
伯乐（Bio-Rad）公司 致力于提供帮助您成功的抗体。我们专注于提供技术、产品及相关所有支持信息以协助您出色完成相关科学研究。
抗体产品包括细胞凋亡试剂盒，自噬检测试剂，CD分子标记物，标签抗体，免疫学研究抗体，神经科学研究抗体和兽医应用试剂等。
伯乐（Bio-Rad）公司在英国拥有经ISO9001和ISO13485认证的生产厂房，同时在德国和美国均设有经ISO9001认证的厂房。
我们专业领域已扩展到传统和重组抗体制备及生产服务。我们的抗体定制服务仅需8周就能完成抗体制备并且成功率在90%以上。我们的体外重组抗体技术能够使得我们筛选制备针对具有挑战性的靶点的抗体，确保长期稳定供货，并能够提供抗体的相应基因序列。
伯乐（Bio-Rad）公司 致力于提供帮助您成功的抗体。我们专注于提供技术、产品及相关所有支持信息以协助您出色完成相关科学研究。